Associations between personality traits and CCK-4-induced panic attacks in healthy volunteers

Psychiatry Research

Volumn 178, Issue 2, 2010, Pages 342-347

  Tõru, Innar ^a   Aluoja, Anu ^a   Võhma, Ülle ^b   Raag, Mait ^a   Vasar, Veiko ^a   Maron, Eduard ^a,b,d   Shlik, Jakov ^c  

^a UNIVERSITY OF TARTU   (Estonia)

^b North Estonia Medical Centre   (Estonia)

^c UNIVERSITY OF OTTAWA   (Canada)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Anxiety; Cholecystokinin

Indexed keywords

TETRAGASTRIN;

ADULT; ANXIETY; ARTICLE; ASSERTIVENESS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; PANIC; PERSONALITY; PRIORITY JOURNAL; VERBAL HOSTILITY;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; PANIC DISORDER; PERSONALITY; PERSONALITY INVENTORY; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; TETRAGASTRIN; YOUNG ADULT;

EID: 77953811692     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2010.04.003     Document Type: Article

References (29)

1. Abelson J.L., Nesse R.M. Pentagastrin infusion in patients with panic disorder. I. Symptoms and cardiovascular responses. Biological Psychiatry 1994, 36:73-83.
2. Abelson J.L., Khan S., Liberzon I., Young E.A. HPA axis activity in patients with panic disorder: review and synthesis of four studies. Depression and Anxiety 2007, 24:66-76.
3. Aluoja A., Shlik J., Vasar V., Kingissepp P.H., Jagomagi K., Vasar E., Bradwejn J. Emotional and cognitive factors associated with response to CCK-4 in healthy volunteers. Psychiatry Research 1997, 66:59-67.
4. Aluoja A., Shlik J., Vasar V., Luuk K., Leinsalu M. Development and psychometric properties of the Emotional State Questionnaire, a self-report questionnaire for depression and anxiety. Nordic Journal of Psychiatry 1999, 53:443-449.
5. Aluoja A., Voogne H., Maron E., Gustavsson J.P., Võhma Ü., Shlik J. Personality traits measured by the Swedish universities Scales of Personality: factor structure and position within the five-factor model in an Estonian sample. Nordic Journal of Psychiatry 2009, 63:231-236.
6. Aronson T.A., Whitaker-Azmitia P., Caraseti I. Differential reactivity to lactate infusions: the relative role of biological, psychological and conditioning variables. Biological Psychiatry 1989, 25:469-481.
7. Austin D.W., Richards J.C. The catastrophic misinterpretation model of panic disorder. Behaviour Research and Therapy 2001, 39:1277-1291.
8. Bond A.J., James D.C., Lader M.H. Physiological and psychological measures in anxious patients. Psychological Medicine 1974, 4:364-373.
9. Bradwejn J., Koszycki D., Shriqui C. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings. Archives of General Psychiatry 1991, 48:603-610.
10. Bradwejn J., Koszycki D., Annable L., Couėtoux du Tetre A., Reines S., Karkanias C.A. Dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder. Biological Psychiatry 1992, 32:903-912.
11. Eser D., Schüle C., Baghai T., Floesser A., Krebs-Brown A., Enunwa M., de la Motte S., Engel R., Kucher K., Rupprecht R. Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteer within a proof-of-concept study. Psychopharmacology 2007, 192:479-487.
12. Eser D., Wenninger S., Baghai T., Schüle C., Rupprecht R. Impact of state and trait anxiety on the panic response to CCK-4. Journal of Neural Transmission 2008, 115(6):917-920.
13. Flint A.J., Koszycki D., Vaccarino F.J., Cadieux A., Boulenger J.P., Bradwejn J. Effect of aging on cholecystokinin-induced panic. American Journal of Psychiatry 1998, 155:283-285.
14. George D.T., Hibbeln J.R., Ragan P.W., Umhau J.C., Phillips M.J., Doty L., Hommer D., Rawlings R.R. Lactate-induced rage and panic in a select group of subjects who perpetrate acts of domestic violence. Biological Psychiatry 2000, 47:804-812.
15. Gustavsson J.P., Bergman H., Edman G., Ekselius L., von Knorring L., Linder J. Swedish universities Scales of Personality (SSP): construction, internal consistency and normative data. Acta Psychiatrica Scandinavica 2000, 102:217-225.
16. Hamilton M. Diagnosis and rating of anxiety. British Journal of Psychiatry 1969, 76-79. Special publication.
17. Katzman M.A., Koszycki D., Bradwejn J. Effects of CCK-tetrapeptide in patients with social phobia and obsessive-compulsive disorder. Depression and Anxiety 2004, 20:51-58.
18. Koszycki D., Bradwejn J. Personality correlates of response to CCK-4 in healthy males. Biological Psychiatry 1997, 42(1S-297S):18S.
19. Koszycki D., Cox B., Bradwejn J. Anxiety sensitivity and response to cholecystokinin-tetrapeptide in healthy volunteers. American Journal of Psychiatry 1993, 150:1881-1883.
20. Koszycki D., Bradwejn J., Zacharko R.M. Influence of personality on behavioral response to cholecystokinin-tetrapeptide in patients with panic disorder. Psychiatry Research 1996, 62:131-138.
21. Koszycki D., Zacharko R.M., Le Melledo J.M., Bradwejn J. Behavioral, cardiaovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers. Depression and Anxiety 1998, 8:1-7.
22. Le Melledo J.M., Merani S., Koszycki D., Palmour R., Gutkowska Y., Bellavance F., Steinberg S.I., Bichet D.G., Bradwejn J. Influences of the menstrual cycle and premenstrual dysphoric disorder on the response to CCK-4. Neuropsychopharmacology 1999, 20:81-91.
23. Radu D., Ahlin A., Svanborg P., Lindefors N. Pentagastrin test for anxiety-psychophysiology and personality. Psychopharmacology 2003, 166:139-145.
24. Schalling D. Psychopathy-related personality variables and the psychophysiology of socialization. Psychopathic Behaviour. Approaches to Research 1978, 85-106. John Wiley and Sons, Chichester. R.D. Hare, D. Schalling (Eds.).
25. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 1998, 59:22-33.
26. Siegel A., Bhatt S., Bhatt R., Zalcman S.S. The neurobiological bases for development of pharmacological treatments of aggressive disorders. Current Neuropharmacology 2007, 5:135-147.
27. Spinhoven P., Onstein E.J., Sterk P.J., Le Haen-Versteijnen D. Discordance between symptom and physiological criteria for the hyperventilation syndrome. Journal of Psychosomatic Research 1993, 37:281-289.
28. Van Megen H.J.G.M., Westenberg H.G.M., den Boer J.A., Haigh J.R., Traub M. Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients. Psychopharmacology 1994, 114:449-455.
29. Võhma Ü., Aluoja A., Vasar V., Shlik J., Maron E. Evaluation of personality traits in panic disorder using Swedish universities Scales of Personality. Journal of Anxiety Disorders 2010, 24:141-146.